Lecanemab appeared to slow down cognitive and functional decline in Alzheimer’s patients in a clinical trial, but there were also adverse effects noted.
Read more: New drug gives hope of slowing cognitive decline in Alzheimer’s patients
Computers Tech Games Crypto Music and More
Lecanemab appeared to slow down cognitive and functional decline in Alzheimer’s patients in a clinical trial, but there were also adverse effects noted.
Read more: New drug gives hope of slowing cognitive decline in Alzheimer’s patients